Mesa Laboratories, Inc. (NASDAQ:MLAB - Get Free Report) Director R Tony Tripeny bought 900 shares of the firm's stock in a transaction on Thursday, August 13th. The stock was purchased at an average price of $113.69 per share, for a total transaction of $102,321.00. Following the completion of the acquisition, the director directly owned 6,298 shares in the company, valued at $716,019.62. The trade was a 16.67% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Mesa Laboratories Stock Performance
Mesa Laboratories stock opened at $107.64 on Tuesday. The firm has a 50 day simple moving average of $100.62 and a 200-day simple moving average of $96.26. The stock has a market cap of $602.78 million, a price-to-earnings ratio of 128.14 and a beta of 0.92. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.79 and a quick ratio of 1.32. Mesa Laboratories, Inc. has a 1-year low of $58.83 and a 1-year high of $115.52.
Mesa Laboratories (NASDAQ:MLAB - Get Free Report) last released its quarterly earnings results on Monday, August 10th. The medical instruments supplier reported $2.68 EPS for the quarter. Mesa Laboratories had a net margin of 1.92% and a return on equity of 22.72%. The firm had revenue of $60.14 million for the quarter.
Mesa Laboratories Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Monday, August 31st will be given a $0.16 dividend. The ex-dividend date is Monday, August 31st. This represents a $0.64 dividend on an annualized basis and a yield of 0.6%. Mesa Laboratories's payout ratio is currently 76.19%.
Analyst Ratings Changes
A number of equities analysts have recently weighed in on the company. Weiss Ratings upgraded Mesa Laboratories from a "sell (d)" rating to a "hold (c-)" rating in a report on Tuesday, August 11th. Wall Street Zen lowered shares of Mesa Laboratories from a "strong-buy" rating to a "buy" rating in a report on Saturday. Finally, Wells Fargo & Company upped their target price on shares of Mesa Laboratories from $94.00 to $110.00 and gave the company an "equal weight" rating in a research report on Friday. Three research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $110.00.
Get Our Latest Research Report on MLAB
Institutional Investors Weigh In On Mesa Laboratories
Institutional investors have recently modified their holdings of the company. Ranger Investment Management L.P. purchased a new stake in shares of Mesa Laboratories in the 2nd quarter valued at $17,321,000. Diamond Hill Capital Management LLC Investment Advisor purchased a new position in Mesa Laboratories during the 2nd quarter valued at about $15,507,000. Boston Partners grew its position in Mesa Laboratories by 2,009.5% in the 3rd quarter. Boston Partners now owns 114,357 shares of the medical instruments supplier's stock valued at $7,664,000 after acquiring an additional 108,936 shares in the last quarter. Millennium Management LLC grew its position in Mesa Laboratories by 131.9% in the 3rd quarter. Millennium Management LLC now owns 133,817 shares of the medical instruments supplier's stock valued at $8,967,000 after acquiring an additional 76,107 shares in the last quarter. Finally, Wasatch Advisors LP increased its stake in Mesa Laboratories by 125.8% during the second quarter. Wasatch Advisors LP now owns 115,668 shares of the medical instruments supplier's stock worth $11,515,000 after purchasing an additional 64,435 shares during the period. 90.60% of the stock is owned by institutional investors and hedge funds.
Mesa Laboratories Company Profile
(
Get Free Report)
Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.
The company's product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
